Replies to post #117991 on Biotech Values

[jq1234]

Per AF tweet of the break of embargo data from ANA by Ivan Oransky:

$TEVA's oral MS drug laquinimod ph 3 results: 23% reduction in relapse rate, 36% reduction in disability progression.